Table 2.

Laboratory data at entry (time of first rituximab infusion), at 12 and 24 months

	Entry, median (IQR) (N=69)	12 months (N=64)	24 months (N=44)
IgG, g/L	8.07 (6.66–9.66)	7.9 (6.04–8.77) z=0.452, p=0.651	6.95 (5.76–8.52) z=2.84, p<0.005
Total peripheral eosinophil count, x109/L	0.26 (0.11–0.77)	0.21 (0.10–0.55) z=0.62, p=0.53	0.22 (0.13–0.34) z=0, p=1.00
C reactive protein, mg/L	4.00 (3.00–9.00)	4.00 (3.00–8.00) Z=3.2, p=0.75	4.00 (2.00–8.00) z=0, p=1.000
Erythrocyte sedimentation rate, mm/hour	9.00 (6.00–19.50)	8.00 (5.00–14.00) z=2.96, p<0.005	7.00 (5.50–12.00) z=−2.46, p=0.01